Documents

Medicine Shoppe-Jonesborough; Revocation of Registration

Federal Register · Notice · Jan 2, 2008

Oregon, 546 U.S. 243, 274 (2006) (citing United States v. Moore, 423 U.S. 122, 135 (1975)). … Moore, 423 U.S. 122, 140-41 (1975) (“In the case of a physician, [the CSA] contemplates that he is authorized by the State to practice medicine and to dispense drugs in connections with his professional

Medical Pharmacy Decision and Order

Federal Register · Notice · Dec 20, 2021

U.S. … Raich, 545 U.S. 1, 13 (2005).

Terese, Inc., D/B/A Peach Orchard Drugs; Admonition of Registrant

Federal Register · Notice · Aug 3, 2011

The DI then contacted the U.S. Attorney's Office and was told that “Duncan Drugs was under indictment for health care fraud.” Id. at 20. … United States, 498 U.S. 395, 407 (1991) (citing Crawford Fitting Co. v. J.T. Gibbons, Inc., 482 U.S. 437, 445 (1987)); see also Bloate v.

Fred Samimi, M.D.; Decision and Order

Federal Register · Notice · Apr 3, 2014

Moore, 423 U.S. 122, 135, 143 (1975)) (“the [CSA's] prescription requirement . . . ensures patients use controlled substances under the supervision of a doctor so as to prevent addiction and recreational … United States, 464 U.S. 16, 23 (1983).

Sigrid Sanchez, M.D.; Decision and Order

Federal Register · Notice · Jul 1, 2013

DEA, 419 F.3d 477, 482 (6th Cir. 2005) (citing Morall v. DEA, 412 F.3d 165, 173-74 (D.C. Cir. 2005)). … Glover Livestock Commission Co., Inc., 411 U.S. 182, 187-88 (1973)).

Gregg & Son Distributors; Grant of Conditional Registration

Federal Register · Notice · Apr 15, 2009

DEA , 419 F.3d 477, 482 (6th Cir. 2005); Morall v. DEA , 412 F.3d 165, 173-74 (DC Cir. 2005). The Government, however, bears the burden of proof. 21 CFR 1301.44(d). … in the general description of the offense.” 511 U.S. at 516 n.5.

Samson K. Orusa, M.D.; Decision and Order

Federal Register · Notice · Jan 19, 2022

Moore, 423 U.S. 122, 135, 143 (1975); Randall L. Wolff, M.D., 77 FR 5,106 (February 1, 2012); Jack A. Danton, D.O., 76 FR 60,900 (September 30, 2011); Robert F. … Moore, 423 U.S. 122, 135, 142-43 (1975)). On May 3, 2017, C.F. tested positive for buprenorphine, a medication typically used to treat opioid use disorder. Tr. 281-82.

Linda Sue Cheek, M.D., Decision and Order

Federal Register · Notice · Oct 28, 2011

(citing U.S. … A September 30, 2008 letter from the U.S.

Dispensing of Controlled Substances to Residents at Long Term Care Facilities

Federal Register · Notice · Jun 29, 2010

Moore, 423 U.S. 122, 136-138 (1975), implicit in the CSA is the requirement that every prescription for a controlled substance must be issued for a legitimate medical purpose by an individual practitioner

Richard A. Herbert, M.D.; Decision and Order

Federal Register · Notice · Aug 30, 2011

Brotherhood of Locomotive Engineers, 482 U.S. 270, 286 (1987). As for the state ALJ's findings, DEA was not a party to that proceeding. … U.S., 128 F.2d 887 (1942). 140  126 S.Ct. 904, 925 (2006) (citing Moore, 423 U.S. 122, 135 (1975)).

Marcia L. Sills, M.D.; Decision and Order

Federal Register · Notice · Aug 4, 2017

Oregon, 546 U.S. 243, 274 (2006) (citing United States v. Moore, 423 U.S. 122, 135, 143 (1975)); United States v. … Volkman, 73 FR 30629, 30642 (2008), pet. for rev. denied, 567 F.3d 215, 223-24 (6th Cir. 2009); see also Moore, 423 U.S. at 142-43 (noting that evidence established that the physician exceeded

David S. Pecora, P.A.; Decision and Order

Federal Register · Notice · Oct 17, 2025

Drug Enf't Admin., 419 F.3d 477, 482 (6th Cir. 2005). … Raich, 545 U.S. at 12-14.

Morris & Dickson Co., LLC; Decision and Order

Federal Register · Notice · May 30, 2023

ALJX 89, at 30 (citing Tr. 409, 423-425). … Jersey City, 322 U.S. 503, 514 (1944) (citing Northern Lines Merger Cases, 396 U.S. 491, 521 (1970)). 97  The delay between the hearing and the issuance of the final decision in this matter

Keith Ky Ly, D.O.; Decision and Order

Federal Register · Notice · May 20, 2015

Brunswick Assoc., 507 U.S. 380, 396 (1993), “do not govern our [DEA] proceedings.”  2 Order on Reconsideration, GX 7, at 8. … DEA, 419 F.3d 477, 482 (6th Cir. 2005). Moreover, while I am required to consider each of the factors, I “need not make explicit findings as to each one.”

Kenneth Harold Bull, M.D.; Decision and Order

Federal Register · Notice · Oct 22, 2013

DEA, 419 F.3d 477, 482 (6th Cir. 2005). Moreover, while I am required to consider each of the factors, I “need not make explicit findings as to each one.” … Columbian Enameling & Stamping Co., 306 U.S. 292, 300 (1939). This conclusion likewise puts to rest the Government's contention that Respondent acted as an unregistered pharmacy.

Trinity Health Care Corp., D/B/A/ Oviedo Discount Pharmacy; Affirmance of Immediate Suspension

Federal Register · Notice · Jun 4, 2007

NLRB , 340 U.S. 474, 496 (1951). Indeed, Mr. Enemchukwu's testimony is implausible. … DEA , 419 F.3d 477, 482 (6th Cir. 2005); see also Morall v. DEA , 412 F.3d 165, 173-74 (D.C. Cir. 2005).

John J. Fotinopoulos; Revocation of Registration

Federal Register · Notice · May 3, 2007

Columbia Enameling & Stamping Co. , 306 U.S. 292, 300 (1939) (“Substantial evidence is more than a scintilla, and must do more than create a suspicion of the existence of the fact to be established.” … DEA , 419 F.3d 477, 482 (6th Cir. 2005); Morall v. DEA , 412 F.3d 165, 173-74 (D.C. Cir. 2005).

Fares Jeries Rabadi, M.D.; Decision and Order

Federal Register · Notice · May 19, 2022

GX 7 at 173, 175-80; see also Tr. 423-24. 73. … Oregon, 546 U.S. 243, 259 (2006).

Hovic Pharmacy; Decision and Order

Federal Register · Notice · Oct 17, 2025

Raich, 545 U.S. 1, at 12 (2005). … U.S. Drug Enf't Admin., 567 F.3d 215, 222 (6th Cir. 2009); Hoxie v. Drug Enf't Admin., 419 F.3d 477, 482 (6th Cir. 2005).

Uvienome Linda Sakor, N.P.; Decision and Order

Federal Register · Notice · Sep 7, 2021

United States, 508 U.S. 223, 237 (1993). The Smith decision involved an offer to trade an automatic weapon for cocaine. 508 U.S. at 225. … United States, 508 U.S. at 238.